Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Michael E. Woods, MD

Advertisement

Articles by Michael E. Woods, MD

Bladder Cancer

Know the gender differences in bladder cancer

ByMarcus L. Quek, MD,Michael E. Woods, MD,Spencer T. Hart, MD
July 26th 2019

Even after diagnosis, female patients with bladder cancer continue to suffer worse outcomes than males following definitive treatment.

Advertisement

Latest Updated Articles

  • Bladder Cancer
    Know the gender differences in bladder cancer

    July 26th 2019



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

FAQ: What does the rename from PCOS to PMOS mean for your patients?

2

Wen Shen, MD, on recognizing perimenopause as a window for healthy aging

3

Preeclampsia Foundation launches postpartum recovery videos for HDP

4

FDA grants priority review to elinzanetant for VMS in women receiving endocrine therapy for breast cancer

5

Gestational hypertension rose 73% from 2016 to 2024, CDC data show

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us